Trastuzumab 440 mg Injection: Uses, Benefits, Dosage, Safety & Frequently Asked Questions

Trastuzumab 440 mg Injection – Comprehensive Information

Trastuzumab 440 mg Injection is a targeted therapy medicine used in the treatment of certain HER2-positive cancers, including breast cancer and gastric (stomach) cancer. It belongs to the class of monoclonal antibodies and works by specifically targeting the HER2 protein found on some cancer cells.

Healthcare professionals prescribe trastuzumab only after confirming HER2-positive status through appropriate diagnostic testing.

What is Trastuzumab 440 mg Injection?

Trastuzumab is a biologic medicine designed to bind to HER2 receptors, helping slow or stop the growth of cancer cells that overexpress HER2.

Common Clinical Uses

• HER2-positive early breast cancer

• HER2-positive metastatic breast cancer

• HER2-positive metastatic gastric or gastroesophageal junction adenocarcinoma

Key Benefits

• Targeted HER2 therapy

• Evidence-based treatment option

• May be used alone or with chemotherapy depending on clinical guidelines

• Administered under medical supervision

• Requires regular cardiac monitoring during treatment

Important Safety Information

• Prescription-only medicine

• Must be administered by qualified healthcare professionals

• Cardiac function should be evaluated before and during treatment

• Not suitable for all patients

• Patients should discuss pregnancy, breastfeeding, and existing heart conditions with their healthcare provider before treatment

Frequently Asked Questions (FAQ)

1. What is Trastuzumab 440 mg Injection used for?

It is used to treat specific HER2-positive breast and gastric cancers as determined by a healthcare professional.

2. How is trastuzumab administered?

It is given as an intravenous infusion in a healthcare setting.

3. Is HER2 testing necessary?

Yes. Treatment is appropriate only for cancers confirmed to be HER2-positive.

4. Can trastuzumab cause side effects?

Like all medicines, it can cause side effects. Patients should discuss potential risks and monitoring requirements with their treating physician.

5. Is this medicine available without a prescription?

No. Trastuzumab is a prescription medicine and should only be used under specialist medical supervision.

Educational Keywords

Trastuzumab 440 mg Injection, HER2 positive breast cancer treatment, HER2 targeted therapy, monoclonal antibody therapy, biologic oncology medicine, breast cancer treatment information, gastric cancer targeted therapy, oncology infusion therapy, cancer biologics, HER2 therapy information

Global Interest Regions

Healthcare providers and institutions in countries including the United States, Canada, United Kingdom, Germany, France, Italy, Spain, Australia, New Zealand, United Arab Emirates, Saudi Arabia, Singapore, Malaysia, South Africa, Brazil, and India may follow international oncology guidelines regarding HER2-targeted therapies.

Major medical and research hubs include New York, Toronto, London, Manchester, Berlin, Paris, Milan, Madrid, Sydney, Melbourne, Dubai, Abu Dhabi, Riyadh, Jeddah, Singapore, Kuala Lumpur, Johannesburg, São Paulo, Mumbai, Delhi, Bengaluru, Hyderabad, and Chennai.

Learn More

For general information about pharmaceutical products and international healthcare services, you can visit:

• Vision Pharma: https://www.visionpharmaexport.com/

• Medicine Exports: https://www.medicineexports.com/

• Global Steroid Pharma: https://www.globalsteroidpharma.com/

• EdMeds Exporter: https://www.edmedsexpoter.com/

Contact

Email: visionpharmaglobal@gmail.com

Phone: +91 9326646654